BOT 6.76% 34.5¢ botanix pharmaceuticals ltd

While still not from BOT so therefore take it with a grain of...

  1. 1,406 Posts.
    lightbulb Created with Sketch. 285
    While still not from BOT so therefore take it with a grain of salt, this is from the E&P report - Page 41

    In the U.S., seven major plans cover approximately 80% of lives, making these engagements crucial. While the progress of these
    negotiations remains somewhat opaque and reliant on optimistic company guidance, it is assumed that Sofdra will be reimbursed at a
    level commensurate with a unit list price of approximately $750 per prescription, with a gross-to-net adjustment of around 30%.
    Last edited by Mikey74: 20/06/24
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
-0.025(6.76%)
Mkt cap ! $633.5M
Open High Low Value Volume
36.5¢ 37.0¢ 34.3¢ $2.048M 5.821M

Buyers (Bids)

No. Vol. Price($)
16 1646659 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 398362 20
View Market Depth
Last trade - 14.30pm 22/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.